登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《BioRxiv，5月9日，Intra-genome variability in the dinucleotide composition of SARS-CoV-2》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-05-10

  • Intra-genome variability in the dinucleotide composition of SARS-CoV-2

    View ORCID ProfilePaul Digard, Hui-Min Lee, Colin Sharp, Finn Grey, View ORCID ProfileEleanor R Gaunt

    doi: https://doi.org/10.1101/2020.05.08.083816

    Abstract

    CpG dinucleotides are under-represented in the genomes of single stranded RNA viruses, and coronaviruses, including SARS-CoV-2, are no exception to this. Artificial modification of CpG frequency is a valid approach for live attenuated vaccine development, and if this is to be applied to SARS-CoV-2, we must first understand the role CpG motifs play in regulating SARS-CoV-2 replication. Accordingly, the CpG composition of the newly emerged SARS-CoV-2 genome was characterised in the context of other coronaviruses. CpG suppression amongst coronaviruses does not significantly differ according to genera of virus, but does vary according to host species and primary replication site (a proxy for tissue tropism), supporting the hypothesis that viral CpG content may influence cross-species transmission. Although SARS-CoV-2 exhibits overall strong CpG suppression, this varies considerably across the genome, and the Envelope (E) open reading frame (ORF) and ORF10 demonstrate an absence of CpG suppression.

    *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.

  • 原文来源：https://www.biorxiv.org/content/10.1101/2020.05.08.083816v1
86浏览量
原文链接
相关报告

  • 《5月8日_SARS-CoV-2双核苷酸组成的基因组内变异》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-05-10
    • 信息名称：SARS-CoV-2双核苷酸组成的基因组内变异 1.时间：2020年5月8日 2.机构或团队：爱丁堡大学 3.事件概要： 爱丁堡大学在bioRxiv预印本平台发表论文“Intra-genome variability in the dinucleotide composition of SARS-CoV-2”。 人工改变CpG频率是研制减毒活疫苗的有效方法，如果要将其应用于SARS-CoV-2，我们必须首先了解CpG基序在调控SARS-CoV-2复制中的作用。冠状病毒对CpG的抑制并不会因病毒属的不同而有显著差异，但会因宿主物种和主要复制位点（代表组织趋向性）的不同而有所不同，这支持了病毒CpG含量可能影响跨物种传播的假设。尽管SARS-CoV-2整体表现出强CpG抑制，但这在整个基因组中存在很大差异，包膜（E）开放阅读框（ORF）和ORF10显示不存在CpG抑制，虽然ORF10只存在于冠状病毒的一个子集的基因组中，但E对病毒复制是必不可少的。在整个冠状病毒科中，E基因在CpG组成中表现出非常高的变异，SARS和SARS-CoV-2的CpG含量比从人类分离的其他冠状病毒高得多。系统发育表明，这是一种来自祖先的性状，起源为蝙蝠，而不是人畜共患转移后选择的性状。 *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用。 4.附件： 原文链接：https://www.biorxiv.org/content/10.1101/2020.05.06.080960v1
    139浏览量
    原文链接

  • 《BioRxiv，5月17日，SARS-CoV-2 amino acid substitutions widely spread in the human population are mainly located in highly conserved segments of the structural proteins》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-05-18
    • SARS-CoV-2 amino acid substitutions widely spread in the human population are mainly located in highly conserved segments of the structural proteins View ORCID ProfileMarti Cortey, Yanli Li, Ivan Diaz, Hepzibar Clilverd, Laila Darwich, Enric Mateu doi: https://doi.org/10.1101/2020.05.16.099499 Abstract The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic offers a unique opportunity to study the introduction and evolution of a pathogen into a completely naive human population. We identified and analysed the amino acid mutations that gained prominence worldwide in the early months of the pandemic. Eight mutations have been identified along the viral genome, mostly located in conserved segments of the structural proteins and showing low variability among coronavirus, which indicated that they might have a functional impact. At the moment of writing this paper, these mutations present a varied success in the SARS-CoV-2 virus population; ranging from a change in the spike protein that becomes absolutely prevalent, two mutations in the nucleocapsid protein showing frequencies around 25%, to a mutation in the matrix protein that nearly fades out after reaching a frequency of 20%. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    24浏览量
    原文链接